This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
She has been on an antipsychotic medication to treat her bipolardisorder for 10 years, resulting in stability of mood symptoms that were previously poorly controlled. How can this be? Let’s review a few case examples. Case 1 “Ms Robbins” is 49 years old and works as a bank teller. On the other hand, Ms Robbins had a much lower score.
In recent years, there has been a growing awareness surrounding the adverse long-term effects of antidepressants, particularly concerning treatment-emergent sexual dysfunction (TESD). Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine.
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. So even their self-judgment is not proof of the merits of the drugs, even for themselves, because they lack knowing what would have been possible for them.
of the patients, and the authors said that their study “provides new evidence to suggest little to no relation between use of a selective serotonin reuptake inhibitor and self-reported suicidal ideation.” Insel is aware of this and promises to investigate why mental health outcomes in the United States are so poor. This is mendacious.
And thanks to education and awareness-raising efforts, more people are getting help with their suffering. Raising awareness about depression, screening for it, and teaching that its common but underdiagnosed, at first glance seem like good things. So its particularly easy to get them to adopt an inferior self-image.
In a study of patients with migraine headache, patients were aware that they might receive a placebo or an anti-migraine medication called Maxalt. Here, the balancing act is self-preservation, if you will, versus patient autonomy. After all, we do call these medications “anti-depressants”, right?
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content